That is the question seemingly unaddressed in the announcement. Reading between the lines 7 completed more than six months treatment and 2 more than 10 months.
Assuming that the 2 patients are not a subset on the 7, that means it appears 5 of 14 didn’t survive 6 months. If median survival is 5.5 months this suggests the median survival isn’t much longer with use of Amplia’s agent.
Cue the outrage from the true believers.
- Forums
- ASX - By Stock
- ATX
- Ann: Update on ACCENT Trial in Pancreatic Cancer
Ann: Update on ACCENT Trial in Pancreatic Cancer, page-33
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.7¢ |
Change
0.007(7.78%) |
Mkt cap ! $24.67M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.6¢ | $15.45K | 156.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31271 | 9.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 32639 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 0.096 |
1 | 18812 | 0.095 |
2 | 38784 | 0.093 |
1 | 100000 | 0.090 |
1 | 10000 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 22318 | 2 |
0.105 | 32631 | 2 |
0.110 | 25000 | 1 |
0.115 | 70000 | 1 |
0.120 | 355000 | 3 |
Last trade - 10.30am 06/08/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |